activity
20112025
most citedAn information-theoretic Phase I/II design for molecularly targeted agents that does not require an assumption of monotonicity

37 citations · 75 across the 30 of their papers we have counts for

collaborators
Showing 2017Show all

5 papers · 1 filter

math.ST2017

A Benchmark for Dose Finding Studies with Continuous Outcomes

Pavel Mozgunov, Thomas Jaki, Xavier Paoletti

An important tool to evaluate the performance of any design is an optimal benchmark proposed by O'Quigley and others (2002, Biostatistics 3(1), 51-56) that provides an upper bound…

math.PR2017

A review of the deterministic and diffusion approximations for stochastic chemical reaction networks

Pavel Mozgunov, Marco Beccuti, Andras Horvath +3

This work reviews deterministic and diffusion approximations of the stochastic chemical reaction networks and explains their applications. We discuss the added value the diffusion…

math.ST2017

An information-theoretic approach for selecting arms in clinical trials

Pavel Mozgunov, Thomas Jaki

The question of selecting the "best" amongst different choices is a common problem in statistics. In drug development, our motivating setting, the question becomes, for example: wh…

stat.ME2017

Subgroup analysis of treatment effects for misclassified biomarkers with time-to-event data

Fang Wan, Andrew C. Titman, Thomas F. Jaki

Analysing subgroups defined by biomarkers is of increasing importance in clinical research. In some situations the biomarker is subject to misclassification error, meaning the true…

math.ST2017★ 2 cited

Loss Functions in Restricted Parameter Spaces and Their Bayesian Applications

Pavel Mozgunov, Thomas Jaki, Mauro Gasparini

Squared error loss remains the most commonly used loss function for constructing a Bayes estimator of the parameter of interest. However, it can lead to sub-optimal solutions when…